Skip to main content
  • Conference Abstract
  • Open access
  • Published:

P.12 Investigating the Role of Glycemic Markers in Pulse Pressure Amplification in Young Adults: The African-PREDICT Study

Abstract

Objective

Pulse pressure amplification (PPA) is described as the amplification of pulse pressure from central arteries to the periphery [1] and individuals with a decreased PPA have an increased risk of cardiovascular disease [2]. Adverse changes in PPA are evident in diabetic populations [3]; however, it is unclear whether PPA differs along varying degrees of glycaemia in young healthy populations. We therefore investigated whether PPA is attenuated with higher levels of glycemic markers and whether PPA is associated with glycemic markers independent of other known risk factors.

Methods

We included 1195 men and women from the African-PREDICT study, aged 20–30 years, with no prior diagnosis of chronic disease. We determined supine central PP (cPP) using the SphygmoCor XCEL device and PPA was defined as the ratio of the amplitude of the PP between the distal and proximal locations (bPP/cPP). Fasting glucose and glycated haemoglobin were determined and the study population was stratified by tertiles of each glycemic marker.

Results

The mean PPA was lower in the highest tertile of fasting glucose when compared to the lowest tertile (1.11 vs. 1.23; p ≤ 0.001). PPA declined with increasing levels of fasting glucose (p–trend ≤ 0.001) after adjustment for age, sex, ethnicity, height, heart rate and mean arterial pressure. In multivariable adjusted regression, we found an independent inverse association between PPA and fasting glucose (β = −0.15, p ≤ 0.001).

Conclusion

PPA decreases with an increase in fasting glucose in adults younger than 30 years, exemplifying early vascular changes which may increase future cardiovascular risk.

Pulse pressure amplification plotted against tertiles of fasting glucose. Values are adjusted for age, sex, heart rate, height and mean arterial pressure. *indicates p-value < 0.05 between the lowest and highest glucose group.

Table Forward stepwise multiple regression analyses between PPA and fasting glucose

References

  1. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, et al. Role of pulse pressure amplification in arterial hypertension: experts’ opinion and review of the data. Hypertension 2009;54:375–83.

    Google Scholar 

  2. Nijdam ME, Plantinga Y, Hulsen HT, Bos WJW, Grobbee DE, van der Schouw YT, et al. Pulse pressure amplification and risk of cardiovascular disease. Am J Hypertens 2008;21:388–92.

    Google Scholar 

  3. Protogerou AD, Blacher J, Mavrikakis M, Lekakis J, Safar ME. Increased pulse pressure amplification in treated hypertensive subjects with metabolic syndrome. Am J Hypertens 2007;20:127–33.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yolandi Breet.

Rights and permissions

This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Breet, Y., Lammertyn, L. & Smith, W. P.12 Investigating the Role of Glycemic Markers in Pulse Pressure Amplification in Young Adults: The African-PREDICT Study. Artery Res 26 (Suppl 1), S32–S33 (2020). https://doi.org/10.2991/artres.k.201209.025

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2991/artres.k.201209.025

Keywords